Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment.
Henriques TB, Dos Santos DZ, Dos Santos Guimarães I, Tessarollo NG, Lyra-Junior PCM, Mesquita P, Pádua D, Amaral AL, Cavadas B, Pereira L, Silva IV, Almeida RMDSG, Rangel LBA.
Henriques TB, et al. Among authors: rangel lba.
Aging (Albany NY). 2021 May 26;13(10):13405-13420. doi: 10.18632/aging.203074. Epub 2021 May 26.
Aging (Albany NY). 2021.
PMID: 34038868
Free PMC article.